Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2020 11:02 ET | Source: Guardion Health Sciences, Inc.

Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line

San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
November 14, 2019 07:00 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019

Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...
October 30, 2019 12:33 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering

San Diego, CA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten...
October 28, 2019 09:21 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering

San Diego, CA, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 24,500,000...
October 23, 2019 07:00 ET | Source: Guardion Health Sciences, Inc.

Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF

San Diego, California, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO for...
October 10, 2019 10:30 ET | Source: Guardion Health Sciences, Inc.

Guardion® Announces Statistically Significant Blood Assay Study Results

Study Results Show 40 Times Higher Blood Concentration Levels of Mesozeaxanthin From Lumega-Z, Guardion’s Flagship Medical Food, as compared to Standard AREDS2 Over-The-Counter Gel Caps San Diego,...
September 23, 2019 10:30 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Acquires the NutriGuard Brand of Products

San Diego, California, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI), through its newly-formed wholly-owned subsidiary, NutriGuard...
September 03, 2019 07:00 ET | Source: Guardion Health Sciences, Inc.

Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test

New Generation of Vision Testing Technology to be Introduced at Vision Expo West San Diego, CA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
August 15, 2019 16:05 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering

San Diego, CA , Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten...
August 15, 2019 08:35 ET | Source: Guardion Health Sciences, Inc.

Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering

San Diego, CA, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), previously announced the pricing of an underwritten public offering of...